Stay Informed
of New Reports
Twitter
Where To Report Waste
Fraud, Abuse, Or Retaliation
Where To Report Waste Fraud, Abuse, Or Retaliation

High-expenditure Medicare drugs often received Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases

Submitting OIG: 
Department of Health & Human Services OIG
Date Issued: 
Tuesday, September 28, 2021
Agency Reviewed / Investigated: 
Department of Health & Human Services
Submitting OIG-Specific Report Number: 
OEI-BL-20-00080
Component, if applicable: 
Food and Drug Administration
Type of Report: 
Inspection / Evaluation
Questioned Costs: 
$0
Funds for Better Use: 
$0
Number of Recommendations: 
1

Related Open Recommendations

No Recommendations found for this Report.

Displaying 0 of 0 Recommendations